Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boxu Lin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 15, 2025
<sup>Allo</sup>ECAR-NKT: New hope for GBM patientsBoxu Lin, Bing Du
Natural Product Reports|March 8, 2024
Gold-catalyzed cyclization and cycloaddition in natural product synthesisBoxu Lin, Tianran Liu, Tuoping Luo
Cancer Cell|April 15, 2025
CAR-T therapy in solid tumorsBing Du, Juliang Qin, Boxu Lin, et al.
Frontiers in Immunology|January 20, 2022
Multi-Omics Analysis for Transcriptional Regulation of Immune-Related Targets Using Epigenetic Data: A New Research DirectionChenshen Huang, Na Zhang, Hao Xiong, et al.
Genome Medicine|June 2, 2025
Pan-cancer analysis identifies CD155 as a promising target for CAR-T cell therapyXiaohong Liu, Yue Sun, Boxu Lin, et al.
Open Biology|August 10, 2022
Multi-omics analysis for potential inflammation-related genes involved in tumour immune evasion via extended application of epigenetic dataChenshen Huang, Ning Wang, Na Zhang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2025
GITRL enhances cytotoxicity and persistence of CAR-T cells in cancer therapyBinghe Tan, Chuntian Tu, Hao Xiong, et al.
Science (New York, N.Y.)|November 13, 2025
Three-component assembly and structure-function relationships of (-)-gukulenin AVaani Gupta, Zechun Wang, Joshua B Combs, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2023
LIGHT/TNFSF14 promotes CAR-T cell trafficking and cytotoxicity through reversing immunosuppressive tumor microenvironmentNa Zhang, Xiaohong Liu, Juliang Qin, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2024
Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignanciesXinfeng Chen, Binghe Tan, Haizhou Xing, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 15, 2025
<sup>Allo</sup>ECAR-NKT: New hope for GBM patientsBoxu Lin, Bing Du
Natural Product Reports|March 8, 2024
Gold-catalyzed cyclization and cycloaddition in natural product synthesisBoxu Lin, Tianran Liu, Tuoping Luo
Cancer Cell|April 15, 2025
CAR-T therapy in solid tumorsBing Du, Juliang Qin, Boxu Lin, et al.
Frontiers in Immunology|January 20, 2022
Multi-Omics Analysis for Transcriptional Regulation of Immune-Related Targets Using Epigenetic Data: A New Research DirectionChenshen Huang, Na Zhang, Hao Xiong, et al.
Genome Medicine|June 2, 2025
Pan-cancer analysis identifies CD155 as a promising target for CAR-T cell therapyXiaohong Liu, Yue Sun, Boxu Lin, et al.
Open Biology|August 10, 2022
Multi-omics analysis for potential inflammation-related genes involved in tumour immune evasion via extended application of epigenetic dataChenshen Huang, Ning Wang, Na Zhang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2025
GITRL enhances cytotoxicity and persistence of CAR-T cells in cancer therapyBinghe Tan, Chuntian Tu, Hao Xiong, et al.
Science (New York, N.Y.)|November 13, 2025
Three-component assembly and structure-function relationships of (-)-gukulenin AVaani Gupta, Zechun Wang, Joshua B Combs, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2023
LIGHT/TNFSF14 promotes CAR-T cell trafficking and cytotoxicity through reversing immunosuppressive tumor microenvironmentNa Zhang, Xiaohong Liu, Juliang Qin, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2024
Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignanciesXinfeng Chen, Binghe Tan, Haizhou Xing, et al.
Pageof 1